Kristin Ermanbriks
Corporate Officer/Principal chez Nexttobe AB
Profil
Ms. Kristin Ermanbriks is a Manager-Corporate Administration at Q-Med AB and Project Coordinator at Nexttobe AB.
Ms. Ermanbriks was previously employed as Executive Assistant by Conpharm AB, Executive Assistant by University of Uppsala, and Marketing Assistant by Pharmacia International BV.
Postes actifs de Kristin Ermanbriks
| Sociétés | Poste | Début |
|---|---|---|
Nexttobe AB
 Nexttobe AB Investment ManagersFinance Nexttobe AB focuses on growth equity investments in healthcare, medical devices, and specialty pharmaceutical companies. It is a venture capital/private equity firm that invests in technology and consumer companies. The company was founded by Bengt Ågerup in 2011 and is headquartered in Uppsala, Sweden. | Corporate Officer/Principal | - |
Anciens postes connus de Kristin Ermanbriks
| Sociétés | Poste | Fin |
|---|---|---|
| Pharmacia International BV | Sales & Marketing | - |
| SLOTTSVIKEN FASTIGHETSAKTIEBOLAG | Corporate Officer/Principal | - |
| University of Uppsala | Corporate Officer/Principal | - |
Q-Med AB
 Q-Med AB Medical SpecialtiesHealth Technology Q-Med AB specializes in aesthetic and corrective solutions. It develops and manufactures brand management for aesthetic and corrective treatments, whereas its portfolio is based on the company’s patented technology, NASHA, for the production of stabilise of non-animal hyaluronic acid. The firm offers portfolio including the brands Restylane, Emervel, Azzalure, Dysport, Deflux, Solesta, and Durolane are other products improving patients’ health in the corrective field. The company was founded by Bengt Agerup on June 17, 1985 and is headquartered in Uppsala, Sweden. | Directeur Administratif | 28/07/2011 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SLOTTSVIKEN FASTIGHETSAKTIEBOLAG | Finance |
| Entreprise privées | 3 |
|---|---|
Q-Med AB
Q-Med AB Medical SpecialtiesHealth Technology Q-Med AB specializes in aesthetic and corrective solutions. It develops and manufactures brand management for aesthetic and corrective treatments, whereas its portfolio is based on the company’s patented technology, NASHA, for the production of stabilise of non-animal hyaluronic acid. The firm offers portfolio including the brands Restylane, Emervel, Azzalure, Dysport, Deflux, Solesta, and Durolane are other products improving patients’ health in the corrective field. The company was founded by Bengt Agerup on June 17, 1985 and is headquartered in Uppsala, Sweden. | Health Technology |
| Pharmacia International BV | |
Nexttobe AB
Nexttobe AB Investment ManagersFinance Nexttobe AB focuses on growth equity investments in healthcare, medical devices, and specialty pharmaceutical companies. It is a venture capital/private equity firm that invests in technology and consumer companies. The company was founded by Bengt Ågerup in 2011 and is headquartered in Uppsala, Sweden. | Finance |
